Stay updated on Chemo +/- Nivolumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Chemo +/- Nivolumab in NSCLC Clinical Trial page.

Latest updates to the Chemo +/- Nivolumab in NSCLC Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3 on the page. The update appears to be a minor backend or interface version bump without altering study details or eligibility.SummaryDifference0.0%

- Check11 days agoChange DetectedThe page now shows revision v3.6.2, replacing the prior v3.6.0. This reflects a small maintenance/patch update to the site framework.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedNew help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Interventions header was reformatted. The page now notes that recruitment has ended and the revision is updated to v3.6.0.SummaryDifference0.5%

- Check32 days agoChange DetectedRevision tag updated to v3.5.5, replacing the previous v3.5.4.SummaryDifference0.0%

- Check47 days agoChange DetectedNo additions or deletions were provided, so there is nothing to summarize for this page.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page's revision label was updated to v3.5.4, replacing the previous v3.5.3. This indicates an update to the study record on ClinicalTrials.gov.SummaryDifference0.1%

Stay in the know with updates to Chemo +/- Nivolumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Chemo +/- Nivolumab in NSCLC Clinical Trial page.